After effective in vitro depletion of the tumor, MSLN.CAR-IL-15 GR1.1-iNK cells were evaluated in a PM mouse model, resulting in potent anti-tumor activity guaranteed by enhanced infiltration and proliferation in tumor masses [171]. The gene discussed is IL15; the disease is neoplasm.